Camlin Fine Sciences has surged 18% to Rs 131 after announcing sub-division of its equity shares.
“The board of directors of the company will meet on November 10 to consider and approve sub-division of the company's equity shares of Rs 10 each into equity shares of Rs 2 each, subject to approval of the shareholders," the company said in a filing to the stock exchanges.
The board will also to take on record the un-audited financial results for the second quarter ended on September 30, 2011, it added.
The stock opened at Rs 112 and hit a new high of Rs 134 on the Bombay Stock Exchange. As many as 52,722 shares have already changed hands on the counter till 1101 hours, against an average less than 7,000 shares traded daily in the past two weeks.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app